scholarly journals Is There a Regular Pattern in the Recovery of Parathyroid Function After Thyroid Cancer Surgery?

2021 ◽  
Vol Volume 13 ◽  
pp. 6891-6899
Author(s):  
Xi-Yu Yao ◽  
Yan Zhou ◽  
Shun-Jin Chen ◽  
Yu Wu ◽  
Cong Bian ◽  
...  
Gland Surgery ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 1093-1103
Author(s):  
Ronghao Sun ◽  
Jianfeng Sheng ◽  
Yue Zhou ◽  
Yuqiu Zhou ◽  
Yongcong Cai ◽  
...  

2020 ◽  
Author(s):  
Xindi Su ◽  
Fang Chai ◽  
Benrui Lin ◽  
Lu Qu ◽  
Keyi Liu ◽  
...  

Abstract Objective. To investigate the application of carbon nanoparticles in lymph node dissection and parathyroid gland protection during thyroid cancer surgery. Subjects and Methods. Retrospective analysis was performed on 282 cases of thyroid cancer surgery in our hospital from 2018 to 2019. All patients underwent total thyroidectomy and cervical central lymph node dissection. Nanocarbon was not used in the control group, but was used in the experimental group. The general situation of the patients, the number of postoperative lymph nodes and the number of metastasis were collected, and the differences between serum parathyroid hormone and blood calcium were compared before and on the 3rd and 30th day after surgery. Results. There was no difference in age, sex and TNM stage between the two groups (P > 0.05). The number of metastatic lymph nodes in the experimental group (9.80 ± 4.80) was different from that in the control group (6.95 ± 3.86) (P < 0.05), and the number of metastatic lymph nodes in the experimental group was different from that in the control group (χ2 = 14.968, P < 0.05). There was no difference in blood calcium and PTH between the two groups before and at 3 and 30 days after surgery (P > 0. 05). Conclusion. The application of carbon nanoparticles in thyroid cancer surgery can significantly increase the number of lymph nodes seized and the positive rate of metastatic lymph node removal, but the protection of parathyroid gland is not obvious.


2011 ◽  
Vol 213 (3) ◽  
pp. S114
Author(s):  
Justin J. Baker ◽  
Michael O. Meyers ◽  
Benjamin F. Calvo ◽  
Jen Jen Yeh ◽  
Karyn B. Stitzenberg

JAMA ◽  
2019 ◽  
Vol 322 (24) ◽  
pp. 2441 ◽  
Author(s):  
Song Vogue Ahn ◽  
Joon-Hyop Lee ◽  
Erin Allana Bove-Fenderson ◽  
So Young Park ◽  
Michael Mannstadt ◽  
...  

Thyroid ◽  
2015 ◽  
Vol 25 (1) ◽  
pp. 3-14 ◽  
Author(s):  
Michael W. Yeh ◽  
Andrew J. Bauer ◽  
Victor A. Bernet ◽  
Robert L. Ferris ◽  
Laurie A. Loevner ◽  
...  

2019 ◽  
Vol 12 ◽  
pp. 117955141986619 ◽  
Author(s):  
Ammar Asban ◽  
Sebastian K Chung ◽  
Rongbing Xie ◽  
Brenessa M Lindeman ◽  
Courtney J Balentine ◽  
...  

Background: Demographic disparities have been described for survival after thyroid cancer surgery using national registries and databases. At the institution level, we hypothesized that assessing survival after thyroid cancer surgery in a long-term cohort with diverse gender and racial groups would reveal disparities in survival. Methods: We examined medical records of patients with papillary or follicular thyroid cancer undergoing thyroidectomy, lobectomy, and other surgical procedures from 1971 to 2016 at a tertiary referral center. We obtained information on demographics, cancer stage, procedure, and radioactive iodine (RAI). We measured survival using Kaplan-Meier estimates and Cox proportional hazards models. Results: A total of 1440 (91%) patients with papillary cancer and 144 (9%) patients with follicular thyroid cancer underwent total thyroidectomy (1297, 82%), lobectomy (261, 16.5%), and other surgical procedures (26, 1.5%). Most patients (1131, 71%) were woman, and 909 (57%) were older than 45 years. Race/ethnicity included 805 (51%) white, 161 (10%) African Americans, and 618 (39%) other race/ethnicities. Both 10- and 20-year survival rates in nonwhite males were worse compared with nonwhite females ( P < .0001). After controlling for age, cancer type, stage, surgical procedure, RAI, and year of surgery, nonwhite males had a higher mortality risk compared with nonwhite females ( P = .0376, confidence interval (CI): 1.03-2.43), white males ( P < .0001, CI: 1.88-6.54), and white females ( P < .0001, CI: 3.31-9.90). Conclusions: Our diverse cohort demonstrates significant gender and racial disparities in survival after thyroid cancer surgery. To improve health outcomes and reduce health disparities among nonwhite males, interventions and long-term care management should target potentially modifiable causes of worse outcomes in this group.


Sign in / Sign up

Export Citation Format

Share Document